scholarly journals Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease

2013 ◽  
Vol 8 (1) ◽  
Author(s):  
Masafumi Sato ◽  
Akihito Mikamo ◽  
Hiroshi Kurazumi ◽  
Ryo Suzuki ◽  
Masanori Murakami ◽  
...  
2020 ◽  
Vol 25 (3) ◽  
pp. 1-1
Author(s):  
Bryn BVSc PhD MRCVS

Summary: Plasma atrial natriuretic peptide and troponin concentrations interpreted together are useful in assessing the severity of mitral valve disease in the dog and are useful measures to augment echocardiographic findings.


2011 ◽  
Vol 189 (3) ◽  
pp. 349-352 ◽  
Author(s):  
Sophia G. Moesgaard ◽  
Torkel Falk ◽  
Tom Teerlink ◽  
Halldóra H. Guðmundsdóttir ◽  
Sif Sigurðardóttir ◽  
...  

2017 ◽  
Vol 19 (2) ◽  
pp. 124-131 ◽  
Author(s):  
Randolph L. Winter ◽  
Ashley B. Saunders ◽  
Sonya G. Gordon ◽  
Jesse S. Buch ◽  
Matthew W. Miller

2018 ◽  
Vol 45 (04) ◽  
pp. 129-134
Author(s):  
I.-Ping Chan ◽  
Tung Hsueh ◽  
Wen-Ying Chen

Two 8-year-old small-breed neutered dogs were referred due to respiratory distress caused by a new onset of congestive heart failure secondary to degenerative mitral valve disease. Medical treatment, including a diuretic and a vasodilator, was initiated, and blood samples for evaluating the levels of blood urea nitrogen, creatinine, and N-terminal pro-brain natriuretic peptide (NT-proBNP) were collected at every visit. The two dogs had entirely different outcomes: one is still alive with its symptoms well controlled by the medications, whereas the other one was unstable during the therapeutic period and only survived for 89 days after the diagnosis was made. Serial measurements of NT-proBNP concentration revealed that its gradual decline corresponded to better outcome, whereas fluctuant and ascending concentrations reflected a poor prognosis.


1992 ◽  
Vol 70 (11) ◽  
pp. 1525-1528 ◽  
Author(s):  
D. A. Wigle ◽  
B. M. Bennett ◽  
D. B. Jennings ◽  
I. R. Sarda ◽  
T. G. Flynn ◽  
...  

Rat brain natriuretic peptide (rBNP) and iso-atrial natriuretic peptide (iso-rANP) were discovered independently by two research laboratories. They are considered to be members of the B-type natriuretic peptides. Except for the Gln/Leu substitution at position 44, the amino acid sequence of iso-rANP is identical with that of the C-terminal 45 amino acids of rat pro-BNP and with the 5-kDa cardiac peptide from rat atria. To determine whether this amino acid substitution can modify the known biological effects of rBNP and iso-rANP, the present investigation examined the cardiovascular and renal responses, vasorelaxant effect, receptor binding characteristics, and cyclic GMP production by the two peptides in relation to that of rat atrial natriuretic peptide (rANP). Results indicate that rBNP and iso-rANP are indistinguishable from each other in terms of these known biological activities of atrial natriuretic peptide. We therefore conclude that rBNP and iso-rANP are identical peptides and that the amino acid substitution at position 44 represents a polymorphic form of the rat B-type natriuretic peptide.Key words: atrial natriuretic peptide, brain natriuretic peptide, cardiovascular response, vasorelaxation, cyclic GMP, receptor binding.


Sign in / Sign up

Export Citation Format

Share Document